“Moderate-certainty evidence” shows that low-cost smoking cessation therapy cytisine “probably” helps more people to quit smoking than a placebo and “low-certainty evidence” suggests that the natural alternative may also help more people to quit than using a nicotine replacement monotherapy, finds a recently published Cochrane Review.
Naturally-derived smoking cessation alternative cytisine is “likely” to help more people to quit smoking than if they were to receive no medical help, says a recently published Cochrane Review.
Currently available OTC in several countries in central and eastern Europe, as well as Canada, cytisine may even help more people quit than using one nicotine
AESGP, MedTech Europe and other associations representing medtech companies including manufacturers of self-care devices call for such products to be included in European Commission proposals for “zero-for-zero” trade in industrial goods between Europe and the US.
Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”
An application for melatonin as an OTC medicine is on the agenda for the next German switch committee meeting, despite the hormone being widely available in food supplements. Acyclovir as a buccal tablet and second-generation antihistamine rupatadine are also up for discussion.
